Andrés Lamsfus-Calle - Search Results

Year	Number of Results
2018	1
2019	2
2020	4
2021	3
2022	2
2023	2
2024	0

1

CRISPR/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation.

Daniel-Moreno A, Lamsfus-Calle A, Raju J, Antony JS, Handgretinger R, Mezger M. Daniel-Moreno A, et al. Among authors: lamsfus calle a. Bone Marrow Transplant. 2019 Dec;54(12):1940-1950. doi: 10.1038/s41409-019-0510-8. Epub 2019 Mar 22. Bone Marrow Transplant. 2019. PMID: 30903024 Review.

2

Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches.

Lamsfus-Calle A, Daniel-Moreno A, Ureña-Bailén G, Raju J, Antony JS, Handgretinger R, Mezger M. Lamsfus-Calle A, et al. Blood Rev. 2020 Mar;40:100641. doi: 10.1016/j.blre.2019.100641. Epub 2019 Nov 15. Blood Rev. 2020. PMID: 31761379 Review.

3

A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy.

Antony JS, Daniel-Moreno A, Lamsfus-Calle A, Raju J, Kaftancioglu M, Ureña-Bailén G, Rottenberger J, Hou Y, Santhanakumaran V, Lee JH, Heumos L, Böhringer J, Krägeloh-Mann I, Handgretinger R, Mezger M. Antony JS, et al. Among authors: lamsfus calle a. CRISPR J. 2022 Feb;5(1):66-79. doi: 10.1089/crispr.2021.0075. Epub 2021 Dec 8. CRISPR J. 2022. PMID: 34882002

4

Generation of a heterozygous and a homozygous CSF1R knockout line from iPSC using CRISPR/Cas9.

Schmitz AS, Korneck M, Raju J, Lamsfus-Calle A, Daniel-Moreno A, Antony JS, Mezger M, Schöls L, Hauser S, Hayer SN. Schmitz AS, et al. Among authors: lamsfus calle a. Stem Cell Res. 2023 Jun;69:103066. doi: 10.1016/j.scr.2023.103066. Epub 2023 Mar 11. Stem Cell Res. 2023. PMID: 36947995 Free article.

5

Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies.

Ureña-Bailén G, Block M, Grandi T, Aivazidou F, Quednau J, Krenz D, Daniel-Moreno A, Lamsfus-Calle A, Epting T, Handgretinger R, Wild S, Mezger M. Ureña-Bailén G, et al. Among authors: lamsfus calle a. CRISPR J. 2023 Feb;6(1):5-16. doi: 10.1089/crispr.2022.0086. Epub 2023 Jan 20. CRISPR J. 2023. PMID: 36662546 Free PMC article.

6

Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.

Hou Y, Ureña-Bailén G, Mohammadian Gol T, Gratz PG, Gratz HP, Roig-Merino A, Antony JS, Lamsfus-Calle A, Daniel-Moreno A, Handgretinger R, Mezger M. Hou Y, et al. Among authors: lamsfus calle a. Genes (Basel). 2022 Dec 13;13(12):2348. doi: 10.3390/genes13122348. Genes (Basel). 2022. PMID: 36553615 Free PMC article.

7

Universal Gene Correction Approaches for β-hemoglobinopathies Using CRISPR-Cas9 and Adeno-Associated Virus Serotype 6 Donor Templates.

Lamsfus-Calle A, Daniel-Moreno A, Ureña-Bailén G, Rottenberger J, Raju J, Epting T, Marciano S, Heumos L, Baskaran P, S Antony J, Handgretinger R, Mezger M. Lamsfus-Calle A, et al. CRISPR J. 2021 Apr;4(2):207-222. doi: 10.1089/crispr.2020.0141. CRISPR J. 2021. PMID: 33876951

8

CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies.

Ureña-Bailén G, Lamsfus-Calle A, Daniel-Moreno A, Raju J, Schlegel P, Seitz C, Atar D, Antony JS, Handgretinger R, Mezger M. Ureña-Bailén G, et al. Among authors: lamsfus calle a. Brief Funct Genomics. 2020 May 20;19(3):191-200. doi: 10.1093/bfgp/elz039. Brief Funct Genomics. 2020. PMID: 31844895

9

Autoantibodies against the immunodominant sCha epitope discriminate the risk of sudden death in chronic Chagas cardiomyopathy.

Rodríguez-Angulo HO, Lamsfus-Calle A, Isoler-Alcaráz J, Galán-Martínez J, Herreros-Cabello A, Callejas-Hernández F, Chorro-de-Villaceballos MA, Maza MC, Santi-Rocca J, Poveda C, Moral-Salmoral JD, Marques J, Mendoza I, Ramírez JD, Guhl F, Carrillo I, Pérez-Tanoira R, Górgolas M, Pérez-Ayala A, Monge-Maillo B, Norman F, Pérez-Molina JA, López-Vélez R, Fresno M, Gironès N. Rodríguez-Angulo HO, et al. Among authors: lamsfus calle a. Ann N Y Acad Sci. 2021 Aug;1497(1):27-38. doi: 10.1111/nyas.14586. Epub 2021 Mar 8. Ann N Y Acad Sci. 2021. PMID: 33682151 Free article.

10

Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34⁺ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin.

Lamsfus-Calle A, Daniel-Moreno A, Antony JS, Epting T, Heumos L, Baskaran P, Admard J, Casadei N, Latifi N, Siegmund DM, Kormann MSD, Handgretinger R, Mezger M. Lamsfus-Calle A, et al. Sci Rep. 2020 Jun 23;10(1):10133. doi: 10.1038/s41598-020-66309-x. Sci Rep. 2020. PMID: 32576837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year